Not sure I'd expect an ATM type drop, but some hype deflation might well be in the books. FPH or RYM could be examples for solid companies suffering hype deflation. Obviously - if the Australian adventure turns pear-shaped, than all bets are off.
Printable View
Over time you should be OK alokdhir.
No company can make small retail shareholders happy - most (even the likes of MFT and FPH) see them as a necessary evil.
Jeff's sent Chris Flood (his right hand man for years) over to Australia to get things moving. He'll manage that well.
Wouldn't guarantee you 15% annual return with Heartland though. You'll get your 7%/8% divie but capital gains over the years have been somewhat muted (because of high payout rate). The share price has a few spikes and a great return year year but often goes nowhere.
Typical is 5 year return from June 2017 when share price was 178 - 60 cents in divie and not much capital gain -overall return just over 4% pa
So to answer your question - Heartland will be OK .... no A2 here .... risk profile has increased a bit .... but your expectations of 15% pa returns might be a bit tough
jeez, if I used a 1% expected return in my FPH DCF model I would get FPH value at about $7
Thanks for your candid response .
I am beginning to think I am better off in GNE then in HGH for yield part of the portfolio . Its more reliable and stable with no such ambitions at work also which can be at crossroads with small investors interests
I am already regretting I diversified my yield portfolio with HGH in it also and not just GNE . But advise which I received here was sound thats why I did as diversification is always useful
Neither was I.....
I emailed them with what we wanted.The power of emails.?
Pleased I applied for a good amount...lol.
Now that HGH have a strong Aussie base ,with Reverse Equity Loans and Stock Co,I think Advance Bank will speed up their growth trajectory.
An exciting rewarding future to be part of..
Can’t blame Jeff for building up HGH’s institutional shareholder base at the expense of small retail shareholders.
Realistically, the institutions are the ones who can pour the hundreds of millions or billions of dollars required to fund growth if he gets the strategy right.
So has he got the strategy right?
Is expansion into Australia really a good idea?
alokdhir, fyi last 5 years TSR returns from HGH have been as below. August years and TSR is change in share price plus gross dividend (not reinvested)
2018 -3%
2019 -2%
2020 -15%
2021 99%
2022 -10%
Hmm .... more down years than up years ...... and From August 17 returns has been 6.1% pa (gross dividends) ..... maybe I've been the mug punter
[QUOTE=percy;972156]Neither was I.....
I emailed them with what we wanted.The power of emails.?
Pleased I applied for a good amount...lol.
Now that HGH have a strong Aussie base ,with Reverse Equity Loans and Stock Co,I think Advance Bank will speed up their growth trajectory.
An exciting rewarding future to be part of..[/QUOT
I have done placements through Chris Lee before after being contacted and thought Craigs would operate the same way so we have learnt a very good lesson...thanks Percy.
Doesn't look like a good investment TBH ...hardly any returns over 5 years time frame
I will pass on this when I get the chance ...wont be buying at 1.80 offer also ...Today sold some at open but now its price is in no mans land ...cant sell cant buy levels ...lol
Jarden client - not previous holder - applied for 12k and have had just over 4k allocated so roughly one-third of my application, with settlement by 29 August. No brokerage incurred, which is normal at least with Jarden on these occasions, and curiously the Contract Note says " CD " despite the placement shares supposedly not being eligible for the dividend. Will have to wait and see on that one but of course the shares trading on-market at the moment are on a CD basis going ex on Friday, so likely that is why.